Document is current
Any future updates will be listed below
-
Authors
Miki, Yuichiro
Bito, Tsubasa
Makuuchi, Rie
Ishizu, Kenichi
Shintani, Ayumi
Terashima, Masanori https://orcid.org/0000-0002-2967-8267
- License Information
-
More Information
Article History
Received: 1 December 2025
Accepted: 18 January 2026
First Online: 25 March 2026
Declarations
:
: There are not any financial or other interests with regard to the submitted manuscript that might be construed as a conflict of interest. YM has received honorarium from Ono Pharmaceutical Co., Ltd.; Bristol Myers Squib Japan K.K.;Merk & Co., Inc.; and Astellas Pharma Inc. RM has received honorarium from Kaken Pharmaceutical Co., Ltd.; MC medical, Inc.; Johnson and Johnson K.K.; Medtronic Japan Co., Ltd.; Intuitive Japan Inc.; and Olympus Co., Ltd. MT has received honorarium from Taiho Pharmaceutical Co., Ltd.; Chugai Pharmaceutical Co., Ltd.; Ono Pharmaceutical Co., Ltd.; Bristol Myers Squib Japan K.K.; Yakult Honsha Co., Ltd.; Takeda Pharmaceutical Co., Ltd.; Eli Lilly Japan K.K.; Pfizer Japan Inc.; Daiichi Sankyo Ltd.; Johnson and Johnson K.K.; Medtronic Japan Co., Ltd.; Intuitive Japan Inc.; and Olympus Co., Ltd.
: All procedures were conducted in accordance with the ethical standards of the relevant institutional and national committees on human experimentation, as well as the 1964 Declaration of Helsinki and its later amendments.
